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Abstract
Clostridium difficile spores play a pivotal role in the transmission of infectious diarrhoea, but in order to cause disease spores
must complete germination and return to vegetative cell growth. While the mechanisms of spore germination are well
understood in Bacillus, knowledge of C. difficile germination remains limited. Previous studies have shown that bile salts and
amino acids play an important role in regulating the germination response of C. difficile spores. Taurocholate, in
combination with glycine, can stimulate germination, whereas chenodeoxycholate has been shown to inhibit spore
germination in a C. difficile clinical isolate. Our recent studies of C. difficile sporulation characteristics have since pointed to
substantial diversity among different clinical isolates. Consequently, in this study we investigated how the germination
characteristics of different C. difficile isolates vary in response to bile salts. By analysing 29 isolates, including 16 belonging to
the BI/NAP1/027 type, we show that considerable diversity exists in both the rate and extent of C. difficile germination in
response to rich medium containing both taurocholate and glycine. Strikingly, we also show that although a potent
inhibitor of germination for some isolates, chenodeoxycholate does not inhibit the germination, or outgrowth, of all C.
difficile strains. Finally, we provide evidence that components of rich media may induce the germination of C. difficile spores,
even in the absence of taurocholate. Taken together, these data suggest that the mechanisms of C. difficile spore
germination in response to bile salts are complex and require further study. Furthermore, we stress the importance of
studying multiple isolates in the future when analysing the nutrients or chemicals that either stimulate or inhibit C. difficile
spore germination.
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Introduction
Clostridium difficile is a Gram-positive, anaerobic spore former
and the major underlying cause of hospital-acquired diarrhoea. C.
difficile infection (CDI) is estimated to affect more than 500,000
people per year in the USA alone and the spread of CDI has led to
patient isolation, ward closures and even hospital closures [1].
Infection with C. difficile may manifest as asymptomatic colonisa-
tion, but can also lead to severe diarrhoea that may then progress
into a potentially fatal pseudo-membranous colitis [2]. Endo-
spores, formed during sporulation, play a pivotal role in the
transmission of disease. Spores shed in the faeces are able to
withstand a variety of cleaning agents and can reside on hospital
surfaces for prolonged periods of time [3]. Therefore, spores are
regarded as the infectious stage of C. difficile. However, following
ingestion by susceptible individuals, the progression to disease
relies first on a return to vegetative cell growth through
germination and then on production of the characteristic toxins
[4].
Germination is defined as the irreversible loss of spore-specific
characteristics and ultimately leads to vegetative cell growth. The
mechanisms of germination have been studied extensively in
Bacillus spp. in which nutrients and chemicals, termed germinants,
can bind to specific receptors at the inner spore membrane [5]. At
this point, the spore becomes committed to germination and
subsequent events include release of monovalent cations (H+, K+
and Na+) and the spores’ large depot of calcium dipicolinic acid
(CaDPA) [6]. This redistribution of ions and water in the spore
core likely precedes the activation of specific lytic enzymes that
degrade the spore cortex, a thick layer of peptidoglycan differing
subtly from vegetative cell peptidoglycan [7,8]. Following cortex
degradation, the spore becomes fully rehydrated, which in turn
allows for a return to enzyme activity, metabolism and, finally,
vegetative cell growth. To date, germination has been studied in
several spore formers, including some Clostridium spp., in which
germinant receptors have been identified [9–11]. However, in C.
difficile the absence of homologues to known germinant receptors
has severely limited research into the mechanisms of germination
in this species [12–14].
The mechanisms by which C. difficile spores sense a suitable
environment for germination have not yet been investigated in
great depth. However, recent work has revealed that bile salts play
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a pivotal role. It has been shown that C. difficile spores can
germinate in response to the secondary bile salt taurocholate,
which acts as a co-germinant with glycine [15,16], and there is
now evidence to suggest that, besides glycine, further amino acids
may also act as co-germinants in combination with taurocholate
[17,18]. Furthermore, recent studies by Sorg and Sonenshein have
described the role of the primary bile salt chenodeoxycholate in
the inhibition of spore germination in a C. difficile clinical isolate
[19,20]. This adds an interesting element to the model of C. difficile
colonisation in the gut. Increasing the concentration of cheno-
deoxycholate has been shown to reduce the efficacy of taurocho-
late as a germinant while, similarly, an increase in the
concentration of taurocholate has been shown to reduce the
inhibitory effect of chenodeoxycholate on germination [20].
However, spores of C. difficile are suggested to have a higher
affinity for chenodeoxycholate than for taurocholate [20].
Therefore, in equal concentrations both cholate and chenodeox-
ycholate derivatives may compete for binding to putative C. difficile
germinant receptors and germination may be inhibited. However,
as the rate of absorption of chenodeoxycholate by the colon is ten
times that of cholate [21], spores reaching the large intestine
encounter a higher concentration of cholate derivatives, such as
taurocholate. This suggests that germination may be inhibited
until C. difficile spores reach the anaerobic environment of the large
bowel, where conditions are suitable for vegetative cell growth.
The recent emergence of so-called ‘hypervirulent’ strains of C.
difficile, such as those belonging to restriction endonuclease type BI,
North American pulsed-field type 1, and PCR-ribotype 027 (BI/
NAP1/027), presents a continuing challenge in healthcare settings
worldwide. Strains belonging to this type are becoming increas-
ingly common among clinical isolates, with some of these strains
thought to be associated with more severe disease and an
expanded repertoire of antibiotic resistance. As a result, under-
standing how these strains might differ from strains less frequently
associated with ‘severe’ disease is of interest [22,23]. Some strains
of the BI/NAP1/027 type are believed to produce higher levels of
toxin in vitro [24] and a number of studies have also concluded that
this type is more prolific in terms of sporulation in vitro than other
C. difficile types [25–30]. However, recent studies have now shown
that BI/NAP1/027 strains do not have an increased sporulation
rate compared with other types and these studies have also
indicated that significant diversity exists in sporulation rates within
the BI/NAP1/027 type [31,32]. Interestingly, our previous studies
of C. difficile sporulation rates have also indicated that the
proportion of spores completing germination to form colonies
may vary significantly among different isolates, suggesting that
differences may exist in the germination response of different C.
difficile strains to taurocholate [31,32]. As germination is a
prerequisite for colonisation, toxin production and subsequent
disease, it is desirable to discover if germination characteristics
vary among important clinical isolates. Furthermore, if variation
exists in the germination response of different C. difficile isolates to
taurocholate, it is conceivable that differences may also exist in the
inhibitory effect of chenodeoxycholate on C. difficile spore
germination.
Here, we sought to investigate the germination and outgrowth
characteristics of different C. difficile isolates (Table 1) in rich
medium containing chenodeoxycholate. We then examined the
differences in the germination response to a medium containing
both taurocholate and glycine. Finally, we aimed to identify
generic germination differences between BI/NAP1/027 and non-
BI/NAP1/027 strains while also studying how the C. difficile
germination response varies within the BI/NAP1/027 type. We
observed substantial diversity in germination characteristics
among our group of clinical isolates and, perhaps most
importantly, noted that chenodeoxycholate does not inhibit the
germination of all C. difficile isolates.
Results
Chenodeoxycholate does not inhibit colony formation
from spores of all C. difficile isolates
Chenodeoxycholate has previously been shown to inhibit spore
germination in a C. difficile clinical isolate [19,20]. As our previous
work has indicated that differences may exist in the germination
properties of different C. difficile isolates [31,32], we elected to analyse
if chenodeoxycholate inhibits the spore germination of nine isolates.
Our initial investigations focused on the ability of dormant spores to
return to vegetative cell growth following incubation with cheno-
deoxycholate. Accordingly, we measured the number of colonies
recovered on BHIS agar following incubation of spores in BHIS
medium supplemented with either 0.1% (w/v) taurocholate alone, or
0.1% (w/v) taurocholate further supplemented with 2 mM cheno-
deoxycholate (a concentration previously shown to inhibit germina-
tion of C. difficile spores and similar to the concentration of bile that
enters the large intestine) [19,33]. As negative controls, colony-
forming units (CFU) were also enumerated on BHIS agar after
incubation of spores in BHIS and dH2O, separately. We observed
that chenodeoxycholate either completely or partially inhibited
colony formation (i.e. the result of germination and outgrowth) from
spores in six of the tested isolates (Fig. 1). When incubated with either
i) BHIS supplemented with taurocholate and chenodeoxycholate; ii)
BHIS alone; or iii) dH2O, R20352 was found to produce 100-fold
fewer CFU/ml compared with taurocholate incubation. Five of the
tested isolates (G,08,0000780, M13042, DH1432, 630Derm, and
R20291) were able to form colonies following incubation with
chenodeoxycholate, although not necessarily to the same level as the
CFU/ml observed after incubation with taurocholate alone (21%,
85%, 85%, 88%, and 95%, respectively compared with taurocholate
alone). Additionally, three of the tested isolates (DH1329, 5108111,
and R9764) were able to produce CFU comparable to the number
observed following incubation with taurocholate alone (i.e. the
positive control) (Fig. 1). Interestingly, we observed that R9764
(PCR-ribotype 081) was able to produce CFU when incubated with
both BHIS alone and dH2O alone (100% and 44%, respectively
compared to taurocholate only). The observation of colony
formation following incubation in dH2O alone can likely be
explained by the fact that the spore suspensions were subsequently
spread onto BHIS agar, where germination could then have
occurred. These data suggest that chenodeoxycholate does not
inhibit spore germination in all C. difficile strains. Furthermore, they
also suggest that spores of some isolates of C. difficile are able to
germinate in the absence of bile salts, in BHIS alone.
Chenodeoxycholate does not inhibit the germination of
all C. difficile isolates
Following the observation that spores of some C. difficile isolates
can complete germination and form colonies in the presence of
chenodeoxycholate, we reasoned that the germination response of
C. difficile spores to chenodeoxycholate may vary. Consequently,
we analysed how the initiation of germination varied when spores
of 15 different C. difficile isolates were exposed to chenodeox-
ycholate. We expressed germination as the loss of optical density at
600 nm (OD600), a known indicator of bacterial spore germination
[20,34]. Accordingly, we measured the loss of OD600 in response
to BHIS supplemented with both 0.1% (w/v) taurocholate and
2 mM chenodeoxycholate. Interestingly, we observed that while
the germination of most isolates appeared to be inhibited by
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chenodeoxycholate, this was not the case with all of the isolates
tested (Fig. 2A and Table 2). Although no isolate germinated to the
same degree as the germination positive control (05-1223-046, a
strain found, in preliminary studies, to exhibit a 74% drop in
OD600 in response to taurocholate), a number of isolates, DH1834
(57%), 5108111 (40%), 7004578 (36%) and CD 2315 (33%) were
able to germinate in the presence of chenodeoxycholate.
Interestingly, when analysing 11 BI/NAP1/027 isolates, two
(DH1834, and 5108111) were able to germinate even in the
presence of chenodeoxycholate, while germination appeared to be
inhibited in spores of the other nine isolates (Fig. 3A). These data
suggest that, despite being a potent inhibitor of spore germination
in many C. difficile isolates (over two-thirds of our entire sample set)
chenodeoxycholate does not universally inhibit spore germination
in all C. difficile strains. Furthermore, variation appears to exist in
the extent of chenodeoxycholate inhibition of germination within
the BI/NAP1/027 type.
Diversity in the germination of C. difficile spores in
response to taurocholate
We have previously reasoned that the proportion of spores that
form colonies may vary from strain to strain, possibly due to
differences in heat resistance and/or germination characteristics
among different C. difficile isolates [31,32]. When measuring the
loss in OD600 of spores of 15 C. difficile isolates (of varying PCR-
ribotypes) during incubation with BHIS supplemented with 0.1%
(w/v) taurocholate (Fig. 2B and Table 2), we observed significant
variation in the germination response among different C. difficile
isolates (p,0.00001). Even though a maximal loss of OD600 was
observed within the first 20 min for most isolates, the final
percentage drop in spore OD600 was considerably different among
our sample of isolates. Starting from a baseline adjusted OD600 of
1, the largest drop in OD600 was found to be 74% (05-1223-046),
while the smallest drop was 42% (CDC 38). This indicates that
different isolates of C. difficile may vary in both their rate and
extent of germination in response to taurocholate.
To evaluate if different concentrations of taurocholate alter the
germination response of C. difficile spores, we incubated spores of
four isolates with BHIS supplemented with either 0.1% or 1% (w/
v) taurocholate (Fig. 4). Interestingly, we again observed
differences among these isolates. For example, CD 2315 was
found to germinate similarly in response to both concentrations of
taurocholate. Conversely, CDC 38 appeared to germinate at a
faster rate when incubated with 1% (w/v) taurocholate than when
Table 1. C. difficile strains used in this study.
Strain name PCR-ribotype Country Source/Reference
9001966 002 The Netherlands Ed Kuijper
G,08,0000780 002 The Netherlands Ed Kuijper
630Derm 012 Laboratory strain [37]
8085054 014 The Netherlands Ed Kuijper
8079089 017 The Netherlands Ed Kuijper
675,1 017 Romania Ed Kuijper
5108111 027 The Netherlands Ed Kuijper
CDC 38 027 USA [38]
M13042 027 Canada [38]
DH1432 027 London, Barnet, UK Val Hall
DH1834 027 East of England, Ipswich, UK Val Hall
DH1466 027 East Midlands, Northampton, UK Val Hall
DH1858 027 NE England,Sunderland, UK Val Hall
DH478 027 SW England, Taunton, UK Val Hall
DH361 027 London, Lewisham, UK Val Hall
DH1329 027 West Midlands, UK Val Hall
R20352 027 Canada Val Hall
R12087 027 Historical EU strain (mid 80 s) Val Hall
R20291 027 Stoke Mandeville, UK Jon Brazier
26131 027 Finland Ed Kuijper
26173 027 Finland Ed Kuijper
05-1223-046 027 Belgium Ed Kuijper
2016 078 Ireland Ed Kuijper
7004578 078 The Netherlands Ed Kuijper
7009825 078 The Netherlands Ed Kuijper
CD 2315 078 Hungary Ed Kuijper
R9764 081 Cardiff, UK Jon Brazier/Ed Kuijper
R12801 106 Bristol, UK Val Hall
R10459 106 Cardiff, UK Jon Brazier/Ed Kuijper
doi:10.1371/journal.pone.0032381.t001
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Figure 1. The CFU/ml formed on BHIS agar by nine C. difficile isolates after incubation with germinants. Spores of C. difficile were heat
treated at 60uC for 25 min. CFU/ml were then enumerated on BHIS agar after 2 h incubation of spores with either i) BHIS supplemented with 0.1% (w/
v) taurocholate (filled bars); ii) BHIS supplemented with 0.1% (w/v) taurocholate and 2 mM chenodeoxycholate (empty bars, diagonal lines); iii) BHIS
alone (empty bars); or iv) dH2O (filled bars, diagonal lines). Colony formation was expressed as the percentage of CFU/ml observed compared to the
CFU/ml observed after incubation with the positive control, BHIS supplemented with taurocholate. The data represent the average of three
independent experiments and error bars indicate the standard errors of the means.
doi:10.1371/journal.pone.0032381.g001
Figure 2. Loss of spore OD600 of C. difficile isolates during incubation in A) BHIS supplemented with taurocholate and
chenodeoxycholate; B) BHIS supplemented with taurocholate; or C) BHIS alone. C. difficile spores were heat treated at 60uC for 25 min and
then incubated in BHIS with or without supplement. Germination was expressed as the loss of spore OD600. A) Loss of OD600 of spores of C. difficile
isolates incubated in BHIS supplemented with 0.1% (w/v) taurocholate and 2 mM chenodeoxycholate.m, DH1834;., 5108111;N, 9001966;n, 26131;#, 7004578; e, CD 2315; and ,, CDC38. The dotted line represents the loss of OD600 of the positive control strain (05-1223-046) in response to BHIS
supplemented with 0.1% (w/v) taurocholate alone. B) Loss of OD600 of spores of C. difficile isolates incubated with BHIS supplemented with 0.1% (w/v)
taurocholate. m, DH1834; ., 5108111;N, DH1432; n 05-1223-046;%, CD 2315; ,, CDC 38; and#, DH1858. The dotted line represents the negative
control strain (DH361) during incubation with both 0.1% (w/v) taurocholate and 2 mM chenodeoxycholate (a strain found, in preliminary studies, not
to germinate when exposed to chenodeoxycholate). C) Loss of OD600 of spores of C. difficile isolates incubated with BHIS alone. m, DH1834; .,
5108111; N, 8085054; n, 05-1223-046;#, 26173; and ,, CDC38. The dotted line represents the loss of OD600 of the positive control strain (05-1223-
046) in response to BHIS supplemented with 0.1% (w/v) taurocholate alone. All data represent the average of three independent experiments and
error bars indicate the standard errors of the means.
doi:10.1371/journal.pone.0032381.g002
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incubated with 0.1% (w/v) taurocholate and CDC 38 also
appeared to show a larger drop in OD600 when exposed to 1%
(w/v) taurocholate. This suggests that different isolates of C. difficile
may vary in their response to different concentrations of
germinants, which could be of interest for future studies.
In keeping with our previous work [31,32], we also sought to
investigate the germination characteristics of 16 BI/NAP1/027
isolates, independent of other PCR-ribotypes. Interestingly, when
examining the germination properties of 11 of these BI/NAP1/
027 isolates spectrophotometrically, we observed significant
variation in both the rate and extent of germination within the
BI/NAP1/027 group in response to taurocholate (p,0.0001), with
the drop in OD600 ranging from 74% in strain 05-1223-046 to
42% in strain CDC 38 (Fig. 3B). These data support our
hypothesis that strains grouped according to a particular typing
method do not necessarily exhibit similar in vitro characteristics.
Rich medium stimulates germination and outgrowth of
C. difficile spores
We observed above that spores of some C. difficile strains were
able to form colonies on BHIS agar, even in the absence of known
germinants such as taurocholate. To assess whether components of
Table 2. Percentage loss of spore optical density after incubation of C. difficile spores with bile salts for 2 h.
Strain name PCR-ribotype 0.1% taurocholate 2 mM chenodeoxycholate BHIS
9001966 002 47% (0.529) 3% (0.968) 11% (0.894)
8085054 014 72% (0.376) 13% (0.868) 38% (0.623)
5108111 027 53% (0.473) 40% (0.599) 27% (0.725)
CDC 38 027 42% (0.580) 12% (0.888) 6% (0.938)
DH1432 027 49% (0.508) 0% (1.031) 15% (0.846)
DH1834 027 58% (0.420) 57% (0.429) 27% (0.734)
DH1466 027 64% (0.355) 0% (1.079) 15% (0.852)
DH1858 027 70% (0.301) 9% (0.910) 23% (0.768)
DH478 027 52% (0.479) 0% (1.113) 5% (0.947)
DH361 027 58% (0.422) 5% (0.947) 9% (0.911)
26131 027 50% (0.500) 0% (1.036) 7% (0.934)
26173 027 46% (0.537) 5% (0.946) 4% (0.961)
05-1223-046 027 74% (0.257) 0% (1.009) 38% (0.623)
7004578 078 46% (0.536) 36% (0.644) 7% (0.926)
CD 2315 078 47% (0.534) 33% (0.671) 21% (0.792)
C. difficile spores were heat treated at 60uC for 25 min and then incubated with either i) BHIS supplemented with 0.1% (w/v) taurocholate; ii) BHIS supplemented with
0.1% (w/v) taurocholate and 2 mM chenodeoxycholate; or iii) BHIS alone. The data represent the average of three independent experiment and numbers in parentheses
represent the mean of the final OD600 value.
doi:10.1371/journal.pone.0032381.t002
Figure 3. Loss of spore OD600 of 11 C. difficile BI/NAP1/027 isolates during incubation in A) BHIS supplemented with taurocholate
and chenodeoxycholate; B) BHIS supplemented with taurocholate; or C) BHIS alone. A), B), and C) m, DH1834; ., DH1432;&, 26173; N,
26131;¤, DH478;n, 05-1223-046;%, DH361;#, DH1858;e, DH1466;,, CDC38; and , 5108111. A) The dotted line represents the loss of OD600 of
the positive control strain (05-1223-046) in response to BHIS supplemented with 0.1% (w/v) taurocholate alone. B) The dotted line represents the
negative control strain (DH361) during incubation with both 0.1% (w/v) taurocholate and 2 mM chenodeoxycholate (a strain found, in preliminary
studies, not to germinate when exposed to chenodeoxycholate). C) The dotted line represents the loss of OD600 of the positive control strain (05-
1223-046) in response to BHIS supplemented with 0.1% (w/v) taurocholate alone. All data represent the average of three independent experiments
and error bars indicate the standard errors of the means.
doi:10.1371/journal.pone.0032381.g003
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BHIS can act as germinants, spores of 15 C. difficile isolates were
incubated with BHIS alone and the loss of OD600 was measured.
Six isolates (8085054, 05-1223-046, DH1834, DH1858, 5108111
and CD 2315) of C. difficile showed a slow but significant (p,0.001)
loss of OD600 (Fig. 2C and Table 2), suggesting that these isolates
are able to germinate in response to BHIS alone. To investigate
whether this germination would lead to vegetative cell growth, we
next measured the change in OD600 of C. difficile cultures over a
20 h time period, during incubation of spores with either BHIS
only or BHIS supplemented with 0.1% (w/v) taurocholate (Fig. 5).
Once more, we observed considerable differences in the growth
properties among strains. The isolates R12087, R12801, R10459,
R20352, 9001966, 5108111, 8079089 and 675,1 were not able to
grow during incubation with BHIS alone, while the isolates
7009825, 7045389, DH1329, 2016, 7004578, R9764 and
G,08,0000780 were able to demonstrate cell growth without
taurocholate supplement (Fig. 5). This suggests that components of
rich media such as BHIS can induce germination of C. difficile
spores, which can subsequently lead to vegetative cell growth.
Discussion
Spores of C. difficile are pivotal for transmission of infection, but
in order to cause disease spores must return to vegetative cell
growth through germination. Bile salts likely play an important
role in C. difficile germination in vivo and it has been shown
previously that chenodeoxycholate can act as an inhibitor of
germination in vitro [16,19,35]. Here, we examined how the
germination response to bile salts varies among spores of 29
different C. difficile isolates. We found that, despite being a potent
inhibitor of spore germination in many isolates, chenodeoxycho-
late did not inhibit the initiation of germination, or the subsequent
vegetative cell outgrowth, in all isolates. We also observed
substantial variation in both the rate and extent of germination
in response to taurocholate among different C. difficile isolates, in
addition to a possible concentration-dependent response to
taurocholate. Furthermore, we provide evidence that components
of a rich medium such as BHIS may be sufficient to induce
germination of C. difficile spores, even in the absence of
taurocholate.
Due to the proposed inhibitory effect on C. difficile spore
germination, chenodeoxycholate has been suggested as a potential
prophylactic drug for the prevention of C. difficile colonisation [20].
However, we have shown in this study that chenodeoxycholate
does not appear to inhibit the spore germination of all C. difficile
strains. Therefore, a drug based on chenodeoxycholate may not be
sufficient for the control of CDI, as its inhibitory action on spore
germination is unlikely to be specific to all strains of C. difficile.
Figure 4. Loss of spore OD600 of four C. difficile isolates during incubation with different concentrations of taurocholate. C. difficile
spores were heat treated at 60uC for 25 min and then incubated in BHIS supplemented with either 0.1% (w/v) taurocholate (#) or 1% (w/v)
taurocholate (N) for 2 h. A) CDC38; B) 7004578; C) 5108111; D) CD2315. The data represent the average of three independent experiments and error
bars indicate the standard errors of the means. The dotted line represents the negative control strain (DH361) during incubation with both 0.1% (w/v)
taurocholate and 2 mM chenodeoxycholate (a strain found, in preliminary studies, not to germinate when exposed to chenodeoxycholate).
doi:10.1371/journal.pone.0032381.g004
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Given our evidence, we suggest that more studies regarding the
germination mechanisms of C. difficile are needed in order to
explore the true potential of germination-based therapeutic drugs.
Although it has been suggested that there is kinetic evidence for
the presence of germinant receptors [16], it is still unknown if
germinants such as taurocholate bind to a receptor or simply
diffuse through the spore and trigger the germination cascade.
Consequently, it is difficult for us to speculate on what the
molecular basis may be for the variation in germination
characteristics that we have observed in this study.
We included 16 BI/NAP1/027 isolates in our study and
observed significant diversity in the germination response to
taurocholate among this group. We have previously found
substantial variation in sporulation characteristics among C. difficile
BI/NAP1/027 isolates [31,32,36]. As a result, the current study
supports our hypothesis that isolates grouped according to a
particular molecular typing technique cannot be assumed to have
identical characteristics. To the contrary, this study indicates that
general conclusions should not be made when discussing the BI/
NAP1/027 type. The use of the term ‘hypervirulent’ should,
therefore, perhaps be restricted to the description of individual
isolates and should only be used when clearly defined and
supported by appropriate clinical data.
In this study we also observed differences in the ease of
preparing pure spore suspensions from different C. difficile isolates.
Repeatedly washing spore suspensions in dH2O was sufficient for
the preparation of pure spores from many C. difficile isolates.
However, we noted that for some isolates it was not possible to
obtain spore suspensions sufficiently free of vegetative cells and cell
debris using this method. Furthermore, even when pure spore
suspensions were prepared, excessive spore clumping in some
isolates prevented the analysis of germination by the loss of spore
OD600, as spore clumping results in a rapid loss of OD600 that may
be misinterpreted as the onset of germination. For that reason, six
of the isolates analysed for colony formation (M13042,
G.08,0000780, R20352, R9764, 630Derm, R20291) were unable
to be studied for loss of OD600. This is an interesting finding and
perhaps reinforces our hypothesis that different C. difficile isolates
exhibit varying in vitro characteristics. Studying these differences in
more detail is a clear area for future studies.
We have uncovered differences in the in vitro germination
response of different C. difficile clinical isolates, but it is still unclear
how these different germination properties relate to in vivo
germination characteristics. Given the likely importance of
germination for C. difficile colonisation, it is interesting that
different isolates appear to germinate at different rates in response
to bile salts. One could speculate that, ideally, a balance of spores
and vegetative cells may need to be maintained in order for C.
difficile to effectively colonise the gut. Therefore, a specific
germination frequency may not only result in a sufficient number
of vegetative cells required for colonisation, but also in a number
of spores that could resist therapeutically administered antibiotics,
such that they could then cause a relapse in disease at a later stage.
However, further investigation is warranted in order to test this
hypothesis.
Materials and Methods
C. difficile isolates and growth conditions
A total of 29 isolates were chosen for analysis (Table 1),
including 16 BI/NAP1/027 isolates and 13 non-BI/NAP1/027
isolates. The non-BI/NAP1/027 group included isolates of PCR-
ribotypes 002, 003, 012, 014, 017 (n= 2), 078 (n= 4), 081, and 106
(n= 2). The chosen isolates included isolates from the UK (n= 11),
the USA, Canada (n = 2), Hungary, Finland (n= 2), Belgium,
Ireland, Romania, and the Netherlands (n = 7), in addition to an
historical EU isolate. C. difficile 630Derm was derived previously
through continuous subculturing of the 630 wild-type strain [37].
Unless otherwise stated, all C. difficile isolates were cultivated at
37uC, in an anaerobic workstation (Don Whitley, United
Kingdom), in BHIS (brain heart infusion supplemented with yeast
extract [5 mg/ml, Oxoid] and L-cysteine [0.1% (w/v), Sigma;
United Kingdom]) broth or agar.
Preparation of C. difficile spores
C. difficile isolates were first cultivated on BHIS agar plates
supplemented with cycloserine (250 mg/ml) and cefoxitin (8 mg/
ml). Overnight cultures of C. difficile were prepared and 100 ml of
these cultures was spread onto BHIS agar. These plates were then
incubated at 37uC under anaerobic conditions for 5 days, to allow
Figure 5. Cell growth from spores of 15 C. difficile isolates. Spores were heat treated at 60uC for 25 min and then incubated with either BHIS
alone (%) or BHIS supplemented with 0.1% (w/v) taurocholate (&). The change in OD600 was measured over 24 h. A) 9001966; B) R12087; C) R12801;
D) 675,1; E) G,08,0000780; F) 7004578; G) 5108111; H) R9764; I) DH1329; J) 8079089; K) R10459; L) 7045389; M) R20352; N) 7009825; O) 2016. The data
represent the average of three independent experiments and error bars indicate the standard errors of the means.
doi:10.1371/journal.pone.0032381.g005
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for efficient sporulation [12,16]. After 5 days, all spores and
vegetative cells were harvested from the plates using cell scrapers
(CostarH, Corning Incorporated, NY, USA) and suspended in
dH2O before incubation overnight at 4uC to encourage the release
of the spore from the mother cell [20]. Spore suspensions were
then washed at least ten times in dH2O (16 0006 g, 4 min).
Following each centrifugation step the supernatant and top layer
of the pellet, containing vegetative cells and cell debris, was
carefully removed. After at least ten washes, spores were re-
suspended in dH2O and checked for purity using phase-contrast
microscopy. Spore suspensions, free of vegetative cells and cell
debris, were stored at 220uC before use.
Measurement of spore germination and outgrowth by
colony formation
To measure the ability of C. difficile spores to complete
germination and form colonies, spore suspensions were heat
treated at 60uC for 25 min to kill any vegetative cells and then
incubated in either i) BHIS; ii) BHIS supplemented with 0.1% (w/
v) taurocholate; iii) BHIS supplemented with both 0.1% (w/v)
taurocholate and 2 mM chenodeoxycholate; or iv) dH2O for 2 h.
Following this incubation, the samples were washed and re-
suspended in phosphate-buffered saline. Samples were then
serially diluted and plated onto unsupplemented BHIS plates.
CFU/ml were enumerated after 24 h incubation. A spo0A mutant,
in which the master regulator of sporulation has been inactivated
[16], was used as a negative control for colony formation after heat
treatment.
Measurement of the germination of C. difficile spores by
loss of optical density
Prior to any spectrophotometric experiments, spore suspensions
were checked, using phase-contrast microscopy, for impurity and
clumping which could interfere with the subsequent OD600
measurements. Spore suspensions which showed extensive impu-
rity and/or clumping were excluded from analyses. Purified spores
were heat treated at 60uC for 25 min to kill any vegetative cells.
Spore suspensions were then adjusted to an OD600 of 1 and 450 ml
of each suspension was used per measurement. Spores were
centrifuged and re-suspended in either BHIS or dH2O, and then
split into three wells of a 96-well plate (for triplicate measure-
ments). To each well, an equivalent volume of the respective
germinant solution was added and germination was measured over
2 h. Heat-treated spore suspensions were germinated in either i)
BHIS; ii) BHIS supplemented with either 0.1% or 1% (w/v)
taurocholate (dissolved in dH2O); or iii) BHIS supplemented with
both 0.1% (w/v) taurocholate and 2 mM chenodeoxycholate
(dissolved in Tris-buffer by pH adjustment with NaOH to pH 8.0).
Germination was expressed as the loss of spore OD600 over time
using an iMarkTM Microplate Absorbance Reader, with 5 sec of
shaking prior to each measurement to avoid adherence of spores to
the wells of the microtitre plate. After measuring OD600 over 2 h
at room temperature, spore suspensions were again examined
using phase-contrast microscopy to identify clumping of spores
during the incubation period. Spore suspensions that showed
evidence of clumping were excluded from the analyses, as spore
clumping can cause a rapid drop in optical density that may be
misinterpreted as the initiation of germination.
Measurement of the return of C. difficile spores to
vegetative cell growth
The return of dormant C. difficile spores to vegetative cell growth
was evaluated by measuring the change in OD600 over a 20 h
period following a 2 h incubation of spores with germinants. First,
spore suspensions were heat treated at 60uC for 25 min to kill any
vegetative cells and then incubated at room temperature for 2 h in
either BHIS alone, or BHIS supplemented with 0.1% (w/v)
taurocholate. Following this incubation, the suspensions were
centrifuged at 80006 g for 4 min and re-suspended in BHIS. The
samples were then incubated at 37uC under anaerobic conditions
and cell growth was measured by the change in OD600 over 20 h
using a microplate reader (TECAN GENiosPro 96/384).
Biological replicates and statistical analyses
All data presented in this manuscript represent the results of
three independent experiments. Statistical analyses were carried
out in GraphPad Prism using one-way analysis of variance with
Tukey’s post hoc compensation for multiple comparisons of
individual isolates.
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